Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross Vlahos

Showing results (21-30 of 150) with videos related to

Pageof 15
Sort By:
Trends in Pharmacological Sciences|October 4, 2011
Suppressing production of reactive oxygen species (ROS) for influenza A virus therapyRoss Vlahos, John Stambas, Stavros Selemidis
Pharmacology & Therapeutics|August 23, 2015
Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbiditiesIvan Bernardo, Steven Bozinovski, Ross Vlahos
British Journal of Pharmacology|October 12, 2023
Targeting accelerated pulmonary ageing to treat chronic obstructive pulmonary disease-induced neuropathological comorbiditiesSimone N De Luca, Ross Vlahos
Trends in Pharmacological Sciences|February 3, 2016
Targeting the IL-33/IL-13 Axis for Respiratory Viral InfectionsChantal Donovan, Jane E Bourke, Ross Vlahos
Laboratory Medicine|May 10, 2026
Examining the benefits of industry clinical placements for medical laboratory science academicsDodie Pouniotis, Lynda Sharp, Ross Vlahos, et al.
Clinical Science (London, England : 1979)|March 23, 2022
Chronic obstructive pulmonary disease and atherosclerosis: common mechanisms and novel therapeuticsKurt Brassington, Stavros Selemidis, Steven Bozinovski, et al.
Pulmonary Pharmacology & Therapeutics|November 16, 2005
What is the contribution of respiratory viruses and lung proteases to airway remodelling in asthma and chronic obstructive pulmonary disease?Rosa C Gualano, Ross Vlahos, Gary P Anderson
Clinical Science (London, England : 1979)|April 14, 2019
New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary diseaseKurt Brassington, Stavros Selemidis, Steven Bozinovski, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 25, 2003
Cromakalim inhibits transmitter acetylcholine release in rat trachea by an action on epithelial cells and a diffusible factorRoss Vlahos, Maurice E Fabiani, David F Story
Pharmacology & Therapeutics|March 20, 2024
Musculoskeletal crosstalk in chronic obstructive pulmonary disease and comorbidities: Emerging roles and therapeutic potentialsKevin Mou, Stanley M H Chan, Ross Vlahos
Pageof 15

Showing results (21-30 of 150) with videos related to

Sort By:
Pageof 15
Trends in Pharmacological Sciences|October 4, 2011
Suppressing production of reactive oxygen species (ROS) for influenza A virus therapyRoss Vlahos, John Stambas, Stavros Selemidis
Pharmacology & Therapeutics|August 23, 2015
Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbiditiesIvan Bernardo, Steven Bozinovski, Ross Vlahos
British Journal of Pharmacology|October 12, 2023
Targeting accelerated pulmonary ageing to treat chronic obstructive pulmonary disease-induced neuropathological comorbiditiesSimone N De Luca, Ross Vlahos
Trends in Pharmacological Sciences|February 3, 2016
Targeting the IL-33/IL-13 Axis for Respiratory Viral InfectionsChantal Donovan, Jane E Bourke, Ross Vlahos
Laboratory Medicine|May 10, 2026
Examining the benefits of industry clinical placements for medical laboratory science academicsDodie Pouniotis, Lynda Sharp, Ross Vlahos, et al.
Clinical Science (London, England : 1979)|March 23, 2022
Chronic obstructive pulmonary disease and atherosclerosis: common mechanisms and novel therapeuticsKurt Brassington, Stavros Selemidis, Steven Bozinovski, et al.
Pulmonary Pharmacology & Therapeutics|November 16, 2005
What is the contribution of respiratory viruses and lung proteases to airway remodelling in asthma and chronic obstructive pulmonary disease?Rosa C Gualano, Ross Vlahos, Gary P Anderson
Clinical Science (London, England : 1979)|April 14, 2019
New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary diseaseKurt Brassington, Stavros Selemidis, Steven Bozinovski, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 25, 2003
Cromakalim inhibits transmitter acetylcholine release in rat trachea by an action on epithelial cells and a diffusible factorRoss Vlahos, Maurice E Fabiani, David F Story
Pharmacology & Therapeutics|March 20, 2024
Musculoskeletal crosstalk in chronic obstructive pulmonary disease and comorbidities: Emerging roles and therapeutic potentialsKevin Mou, Stanley M H Chan, Ross Vlahos
Pageof 15